XML 21 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Changes in Redeemable Perpetual Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)
shares in Thousands, $ in Thousands
Total
Series A Preferred Stock
Member’s Equity
Common Stock
Common Stock
Series A Preferred Stock
Additional Paid-In Capital
Additional Paid-In Capital
Series A Preferred Stock
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2019     1            
Beginning balance at Dec. 31, 2019     $ 305,151            
Beginning balance (in shares) at Dec. 31, 2019       0          
Beginning balance at Dec. 31, 2019 $ 305,151     $ 0   $ 0   $ 0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Special distribution (589,000)   (589,000)            
Initial public offering of common stock, net of underwriting discounts and commissions (in shares)       7,000          
Initial public offering of common stock, net of underwriting discounts and commissions 145,532     $ 7   145,525      
Deferred offering costs (6,464)         (6,464)      
Stock compensation expense 4,809   3,397     1,412      
Net income (loss) 59,073   $ 71,394         (12,321)  
Corporate conversion and stock split (in shares)     (1) 119,994          
Corporate conversion and stock split 0   $ 209,058 $ 120       (209,178)  
Ending balance (in shares) at Dec. 31, 2020     0            
Ending balance at Dec. 31, 2020     $ 0            
Ending balance (in shares) at Dec. 31, 2020       126,994          
Ending balance at Dec. 31, 2020 $ (80,899)     $ 127   140,473   (221,499) $ 0
Ending balance (in shares) at Dec. 31, 2020 0                
Ending balance at Dec. 31, 2020 $ 0                
Beginning balance (in shares) at Dec. 31, 2019       0          
Beginning balance at Dec. 31, 2019 305,151     $ 0   0   0  
Increase (Decrease) in Permanent Equity [Roll Forward]                  
Equity-based compensation 4,809   3,397     1,412      
Issuance of stock, net (in shares)       7,000          
Issuance of stock, net 145,532     $ 7   145,525      
Net (loss) 59,073   $ 71,394         (12,321)  
Ending balance (in shares) at Dec. 31, 2020       126,994          
Ending balance at Dec. 31, 2020 (80,899)     $ 127   140,473   (221,499) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Initial public offering of common stock, net of underwriting discounts and commissions (in shares)       7,875          
Initial public offering of common stock, net of underwriting discounts and commissions 104,764     $ 8   104,756      
Stock compensation expense 13,562         13,562      
Net income (loss) (50,403)             (50,403)  
Ending balance (in shares) at Dec. 31, 2021       135,027          
Ending balance at Dec. 31, 2021 $ (69,205)     $ 135   202,562   (271,902) 0
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Issuance of Series A Preferred, net of fees (in shares) 350                
Issuance of Series A Preferred, net of fees $ 229,799                
Preferred cumulative dividends plus accretion 8,226                
Payment of dividends (8,052)                
Preferred accretion $ 7,489                
Ending balance (in shares) at Dec. 31, 2021 350                
Ending balance at Dec. 31, 2021 $ 237,462                
Beginning balance (in shares) at Dec. 31, 2020       126,994          
Beginning balance at Dec. 31, 2020 (80,899)     $ 127   140,473   (221,499) 0
Increase (Decrease) in Permanent Equity [Roll Forward]                  
Equity-based compensation (in shares)       158          
Equity-based compensation 13,562         13,562      
Issuance of stock, net (in shares)       7,875          
Issuance of stock, net 104,764     $ 8   104,756      
Deferred tax impact of capped call (40,514)         (40,514)      
Preferred cumulative dividends plus accretion (8,226)         (8,226)      
Preferred accretion (7,489)         (7,489)      
Net (loss) (50,403)             (50,403)  
Ending balance (in shares) at Dec. 31, 2021       135,027          
Ending balance at Dec. 31, 2021 (69,205)     $ 135   202,562   (271,902) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Initial public offering of common stock, net of underwriting discounts and commissions (in shares)       15,147          
Initial public offering of common stock, net of underwriting discounts and commissions   $ 215,878     $ 15   $ 215,863    
Stock compensation expense 4,413         4,413      
Net income (loss) (25,937)             (25,937)  
Ending balance (in shares) at Mar. 31, 2022       150,174          
Ending balance at Mar. 31, 2022 $ 170,218     $ 150   411,232   (297,839) 56,675
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Issuance of Series A Preferred, net of fees (in shares) 50                
Issuance of Series A Preferred, net of fees $ 32,724                
Preferred cumulative dividends plus accretion $ 11,606                
Ending balance (in shares) at Mar. 31, 2022 400                
Ending balance at Mar. 31, 2022 $ 281,792                
Beginning balance (in shares) at Dec. 31, 2021       135,027          
Beginning balance at Dec. 31, 2021 (69,205)     $ 135   202,562   (271,902) 0
Increase (Decrease) in Permanent Equity [Roll Forward]                  
Equity-based compensation 4,413         4,413      
Issuance of stock, net (in shares)       15,147          
Issuance of stock, net   215,878     $ 15   215,863    
Preferred cumulative dividends plus accretion (11,606)         (11,606)      
Net (loss) (25,937)             (25,937)  
Other comprehensive income 56,675               56,675
Ending balance (in shares) at Mar. 31, 2022       150,174          
Ending balance at Mar. 31, 2022 170,218     $ 150   411,232   (297,839) 56,675
Beginning balance (in shares) at Dec. 31, 2021       135,027          
Beginning balance at Dec. 31, 2021 (69,205)     $ 135   202,562   (271,902) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Initial public offering of common stock, net of underwriting discounts and commissions (in shares)         15,252        
Initial public offering of common stock, net of underwriting discounts and commissions   215,498     $ 15   215,483    
Stock compensation expense 7,357         7,357      
Net income (loss) (30,961)             (30,961)  
Ending balance (in shares) at Jun. 30, 2022       150,279          
Ending balance at Jun. 30, 2022 $ 110,368     $ 150   401,614   (302,863) 11,467
Beginning balance (in shares) at Dec. 31, 2021 350                
Beginning balance at Dec. 31, 2021 $ 237,462                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Issuance of Series A Preferred, net of fees (in shares) 50                
Issuance of Series A Preferred, net of fees $ 32,724                
Preferred cumulative dividends plus accretion (in shares) 13                
Preferred cumulative dividends plus accretion $ 23,788                
Ending balance (in shares) at Jun. 30, 2022 413                
Ending balance at Jun. 30, 2022 $ 293,974                
Beginning balance (in shares) at Dec. 31, 2021       135,027          
Beginning balance at Dec. 31, 2021 (69,205)     $ 135   202,562   (271,902) 0
Increase (Decrease) in Permanent Equity [Roll Forward]                  
Equity-based compensation 7,357         7,357      
Issuance of stock, net (in shares)         15,252        
Issuance of stock, net   215,498     $ 15   215,483    
Preferred cumulative dividends plus accretion (23,788)         (23,788)      
Net (loss) (30,961)             (30,961)  
Other comprehensive income 11,467               11,467
Ending balance (in shares) at Jun. 30, 2022       150,279          
Ending balance at Jun. 30, 2022 110,368     $ 150   401,614   (302,863) 11,467
Beginning balance (in shares) at Dec. 31, 2021       135,027          
Beginning balance at Dec. 31, 2021 (69,205)     $ 135   202,562   (271,902) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Initial public offering of common stock, net of underwriting discounts and commissions (in shares)         15,146        
Initial public offering of common stock, net of underwriting discounts and commissions   214,906     $ 15   214,891    
Stock compensation expense 11,454         11,454      
Net income (loss) 9,683             9,683  
Ending balance (in shares) at Sep. 30, 2022       150,334          
Ending balance at Sep. 30, 2022 $ 111,453     $ 150   392,862   (262,219) (19,340)
Beginning balance (in shares) at Dec. 31, 2021 350                
Beginning balance at Dec. 31, 2021 $ 237,462                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Issuance of Series A Preferred, net of fees (in shares) 50                
Issuance of Series A Preferred, net of fees $ 32,724                
Preferred cumulative dividends plus accretion (in shares) 13                
Preferred cumulative dividends plus accretion $ 36,045                
Dividends paid (in shares) (13)                
Dividends paid $ (18,670)                
Ending balance (in shares) at Sep. 30, 2022 400                
Ending balance at Sep. 30, 2022 $ 287,561                
Beginning balance (in shares) at Dec. 31, 2021       135,027          
Beginning balance at Dec. 31, 2021 (69,205)     $ 135   202,562   (271,902) 0
Increase (Decrease) in Permanent Equity [Roll Forward]                  
Equity-based compensation (in shares)       161          
Equity-based compensation 11,454         11,454      
Issuance of stock, net (in shares)         15,146        
Issuance of stock, net   214,906     $ 15   214,891    
Preferred cumulative dividends plus accretion (36,045)         (36,045)      
Net (loss) 9,683             9,683  
Other comprehensive income (19,340)               (19,340)
Ending balance (in shares) at Sep. 30, 2022       150,334          
Ending balance at Sep. 30, 2022 111,453     $ 150   392,862   (262,219) (19,340)
Beginning balance (in shares) at Dec. 31, 2021       135,027          
Beginning balance at Dec. 31, 2021 (69,205)     $ 135   202,562   (271,902) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Initial public offering of common stock, net of underwriting discounts and commissions (in shares)       15,147          
Initial public offering of common stock, net of underwriting discounts and commissions 216,078 (1,938)   $ 15   216,063 (1,938)    
Stock compensation expense 14,543         14,543      
Net income (loss) 4,432             4,432  
Ending balance (in shares) at Dec. 31, 2022       150,513          
Ending balance at Dec. 31, 2022 $ 124,281     $ 150   383,176   (267,470) 8,425
Beginning balance (in shares) at Dec. 31, 2021 350                
Beginning balance at Dec. 31, 2021 $ 237,462                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Issuance of Series A Preferred, net of fees (in shares) 50                
Issuance of Series A Preferred, net of fees $ 32,724                
Preferred cumulative dividends plus accretion (in shares) 19                
Preferred cumulative dividends plus accretion $ 48,054                
Dividends paid (in shares) (13)                
Dividends paid $ (18,670)                
Ending balance (in shares) at Dec. 31, 2022 406                
Ending balance at Dec. 31, 2022 $ 299,570                
Beginning balance (in shares) at Dec. 31, 2021       135,027          
Beginning balance at Dec. 31, 2021 (69,205)     $ 135   202,562   (271,902) 0
Increase (Decrease) in Permanent Equity [Roll Forward]                  
Equity-based compensation (in shares)       339          
Equity-based compensation 14,543         14,543      
Issuance of stock, net (in shares)       15,147          
Issuance of stock, net 216,078 (1,938)   $ 15   216,063 (1,938)    
Preferred cumulative dividends plus accretion (48,054)         (48,054)      
Net (loss) 4,432             4,432  
Other comprehensive income 8,425               8,425
Ending balance (in shares) at Dec. 31, 2022       150,513          
Ending balance at Dec. 31, 2022 124,281     $ 150   383,176   (267,470) 8,425
Beginning balance (in shares) at Mar. 31, 2022       150,174          
Beginning balance at Mar. 31, 2022 170,218     $ 150   411,232   (297,839) 56,675
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Initial public offering of common stock, net of underwriting discounts and commissions   (380)         (380)    
Stock compensation expense 2,944         2,944      
Net income (loss) (5,024)             (5,024)  
Ending balance (in shares) at Jun. 30, 2022       150,279          
Ending balance at Jun. 30, 2022 $ 110,368     $ 150   401,614   (302,863) 11,467
Beginning balance (in shares) at Mar. 31, 2022 400                
Beginning balance at Mar. 31, 2022 $ 281,792                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Preferred cumulative dividends plus accretion (in shares) 13                
Preferred cumulative dividends plus accretion $ 12,182                
Ending balance (in shares) at Jun. 30, 2022 413                
Ending balance at Jun. 30, 2022 $ 293,974                
Beginning balance (in shares) at Mar. 31, 2022       150,174          
Beginning balance at Mar. 31, 2022 170,218     $ 150   411,232   (297,839) 56,675
Increase (Decrease) in Permanent Equity [Roll Forward]                  
Equity-based compensation (in shares)       105          
Equity-based compensation 2,944         2,944      
Issuance of stock, net   (380)         (380)    
Preferred cumulative dividends plus accretion (12,182)         (12,182)      
Net (loss) (5,024)             (5,024)  
Other comprehensive income (45,208)               (45,208)
Ending balance (in shares) at Jun. 30, 2022       150,279          
Ending balance at Jun. 30, 2022 110,368     $ 150   401,614   (302,863) 11,467
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Initial public offering of common stock, net of underwriting discounts and commissions   (592)         (592)    
Stock compensation expense 4,097         4,097      
Net income (loss) 40,644             40,644  
Ending balance (in shares) at Sep. 30, 2022       150,334          
Ending balance at Sep. 30, 2022 111,453     $ 150   392,862   (262,219) (19,340)
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Preferred cumulative dividends plus accretion $ 12,257                
Dividends paid (in shares) (13)                
Dividends paid $ (18,670)                
Ending balance (in shares) at Sep. 30, 2022 400                
Ending balance at Sep. 30, 2022 $ 287,561                
Beginning balance (in shares) at Jun. 30, 2022       150,279          
Beginning balance at Jun. 30, 2022 110,368     $ 150   401,614   (302,863) 11,467
Increase (Decrease) in Permanent Equity [Roll Forward]                  
Equity-based compensation (in shares)       55          
Equity-based compensation 4,097         4,097      
Issuance of stock, net   $ (592)         $ (592)    
Preferred cumulative dividends plus accretion (12,257)         (12,257)      
Net (loss) 40,644             40,644  
Other comprehensive income (30,807)               (30,807)
Ending balance (in shares) at Sep. 30, 2022       150,334          
Ending balance at Sep. 30, 2022 $ 111,453     $ 150   $ 392,862   $ (262,219) $ (19,340)